OSPOLOT 20mg / ml oral suspension medication leaflet

N03AX03 sultiam • Nervous system | Antiepileptics | Other antiepileptics

Sultiame is a medication used in the treatment of epilepsy, particularly in focal seizures and Lennox-Gastaut syndrome. It works by inhibiting carbonic anhydrase, reducing neuronal excitability and preventing seizures.

The medication is taken orally, as directed by a doctor, usually two or three times daily. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.

Patients should be aware of potential side effects, such as fatigue, dizziness, or gastrointestinal disturbances. It is important to inform the doctor of any unusual symptoms.

Common side effects include fatigue, dizziness, nausea, and loss of appetite. In rare cases, severe reactions such as metabolic acidosis or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about OSPOLOT 20mg / ml

Substance: sultiam

Date of last drug list: 01-08-2024

Commercial code: W70428001

Concentration: 20mg / ml

Pharmaceutical form: oral suspension

Quantity: 1

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: DESITIN ARZNEIMITTEL GMBH - GERMANIA

Holder: DESITIN ARZNEIMITTEL GMBH - GERMANIA

Number: 15526/2024/01

Shelf life: 3 years-after packing for marketing;after the first opening of the bottle-3 months